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Abstract
Background: Real time three dimensional (RT3D) echocardiography is an accurate and reproducible method for
assessing left ventricular shape and function.
Aim: assess the feasibility and reproducibility of RT3D stress echocardiography (SE) (exercise and pharmacological)
in the evaluation of left ventricular function compared to 2D.
Methods and results: One hundred eleven patients with known or suspected coronary artery disease underwent
2D and RT3DSE. The agreement in WMSI, EDV, ESV measurements was made off-line.
The feasibility of RT-3DSE was 67%. The inter-observer variability for WMSI by RT3D echo was higher during exer-
cise and with suboptimal quality images (good: k = 0.88; bad: k = 0.69); and with high heart rate both for pharma-
cological (HR < 100 bpm, k = 0.83; HR ≥ 100 bpm, k = 0.49) and exercise SE (HR < 120 bpm, k = 0.88; HR ≥ 120
bpm, k = 0.78). The RT3D reproducibility was high for ESV volumes (0.3 ± 14 ml; CI 95%: -27 to 27 ml; p = n.s.).
Conclusions: RT3DSE is more vulnerable than 2D due to tachycardia, signal quality, patient decubitus and
suboptimal resting image quality, making exercise RT3DSE less attractive than pharmacological stress.
Two-dimensional SE is an established and validated
method for both diagnosis and prognosis in patients
with known or suspected coronary artery disease [1-5].
However, grounds for an accurate interpretation in SE
rely on two important features: firstly, acoustic windows
that allow complete endocardial border visualization
within proper planes of the left ventricle (LV) and sec-
ondly, prompt acquisition of peak images pertaining to
predictive accuracy. The introduction of RT-3D permits
single-window acquisition of complete LV segments in a
volume-shaped cine-loop [6], and may have the prere-
quisite to benefit SE. Furthermore, a high level of opera-
tor skill is not required to obtain diagnostic quality
RT-3D images and as demonstrated in other studies, the
total study time needed to complete an RT-3D SE is
shorter than for 2D stress echocardiography [7-12]. The
aim of this study was to assess the feasibility and repro-
ducibility of RT-3D SE in the evaluation of regional and
global left ventricular function: WMSI, EDV, ESV of left
ventricle, compared to conventional 2D echo in a high-
volume stress echo laboratory employing all types of




The study population consisted of 111 (age 64 ±
11 years, 72 males) unselected consecutive patients eval-
uated prospectively in the echo lab of the Institute of
Clinical Physiology from April 2007 to February 2008,
and who underwent stress echocardiography for known
or suspected coronary artery disease. Indication for
stress echocardiography was suspected coronary artery
disease. Inclusion criteria were: age ≥ 18 years; adequate
echocardiogram to assess regional wall motion in 2D
(the echocardiogram was considered adequate if ≥ 13 of
the 17 segments were visualized in at least one projec-
tion). The stressor used (51 exercise, 31 dipyridamole
and 29 dobutamine) was chosen on the basis of specific
contraindications, local facilities and physician’s prefer-
ences. Pharmacological stress echocardiography was
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or when the exercise electrocardiography result was not
diagnostic or was inconclusive. Stress echocardiography
were performed on anti-anginal medical therapy in 66
subjects (60%) (b-blockers in 53, calcium-antagonists in
20, or nitrates in 15) and off therapy in 45 (40%)
patients. Informed consent was obtained from all
patients before testing, and the study protocol was
approved by the institutional review board.
2D imaging
2D echocardiography images were obtained with iE 33
(Philips Medical Systems, Palo Alto, Calif., USA)
equipped with a phased array 1.6-2.5 MHz probe with
second harmonic capability. In all patients, four stan-
dard views (parasternal long and short axis, apical 4 and
2 chambers) were obtained at baseline and peak stress
and were digitally stored.
RT 3D imaging
Real-time three-dimensional echocardiography images
were stored using a matrix-array transducer (X3-1, 1,9/
3,8 MHz) connected to a commercial ultrasound
machine (IE 33, Philips Medical Systems, Andover,
Mass) at baseline and peak stress immediately after 2D
acquisition. The RT3D acquisitions were performed in
apical view, taking care to optimize the image quality
and to include the entire LV cavity within the pyramidal
volume scan by using the biplane format. For each
patient three different RT3D echo acquisitions were
made in standard apical view. RT3D data sets were
acquired during breath-holding using a wide-angle
acquisition (92 × 83 degrees) mode in which four
wedge-shaped sub volumes were obtained from four
consecutive cardiac cycles with the acquisition triggered
to the R wave of the ECG. Before storage, the visualiza-
tion of LV endocardial borders in the orthogonal and
transverse planes was checked. 3D data sets were trans-
ferred to a computer for off-line analysis using available
commercial software (3DQ ADV, Qlab version 5.0, Phi-
lips). Off-line qualitative and quantitative analyses of
regional LV function were performed by two investiga-
tors experienced in interpreting RT3D images in stan-
dard apical views, and who were unaware of the results
of all prior evaluation. Qualitative analysis of 3D LV
regional function was done by visual evaluation of wall
motion performed on 2D planes reconstructed from the
pyramidal volume data set cropped so as to reproduce
the 4 and 2 chambers and scored by WMSI. Briefly,
from the automatically-traced endocardial borders
(manually corrected when indicated) in all frames of the
cardiac cycle, a global LV function curve was generated
to obtained end-diastolic volume, end-systolic volume,
and ejection fraction. The left ventricle was divided into
17 segments from base to apex and regional volume
changes were computed over the cardiac cycle and
displayed as waveforms. Acquisition of baseline and
peak 3D images were obtained after 2D studies using
the same echocardiographic machine with a rapid switch
between the two probes.
Stress protocol
Exercise stress echo was conducted using a semi-supine
bicycle ergometer with 25 W incremental loading every
2 min. Dipyridamole (up to 0.84 mg over 6 min) and
dobutamine (up to 40 mg/kg/min with co-administra-
tion of atropine up to 1 mg) stress echo were performed
according to the well-established protocols [13]. Echo-
cardiographic images were semi-quantitatively assessed
using a 17-segment, 4-point scale model of the left ven-
tricle [13]. A wall motion score index was derived by
dividing the sum of individual segment scores by the
number of interpretable segments. Ischemia was defined
as stress-induced new and/or worsening of pre-existing
wall motion abnormality, or biphasic response (i.e. low-
dose improvement followed by high-dose deterioration).
Necrotic pattern was akinetic or dyskinetic myocardium
with no thickening during stress. A test was normal in
the case of no rest and stress wall motion abnormality.
Image review and analysis
Segmental analysis (wall motion and image quality) for
2D and for RT-3D stress echo was independently and
blindly reviewed off-line by two expert echocardiogra-
phers. The quality was assessed for each stress test both
for 2D and 3D echocardiogram on a three-point scale:
2 optimal/good = complete endocardial definition and
wall thickening with exactly similar image views for 2D
and 3D echocardiogram; 1 fair = inadequate visualiza-
tion of one or two segments but adequate visualization
of adjacent segments within the same territory; 0 poor =
inadequate visualization of three or more segments of
the same territory but adequate visualization of adjacent
segments within the same territory.
Statistics
Continuous variables were expressed as the mean value ±
SD, and as numbers (percent) for categorical variables.
Correlations were performed with linear regression and
Pearson’s coefficient.
The 2D and 3D measurements were evaluated by cal-
culating the intra- and inter-observer variability of each
technique, which was defined as the absolute mean of
the difference between the corresponding repeated mea-
surements. The reproducibility between 2D and 3D
measurements, 3D observer 1° and 3D observer 2° mea-
surements were evaluated using Bland-Altman analysis
by calculating the bias (mean difference) and the 95%
limits of agreement (1.96*SD around the mean differ-
ence). The significance of the biases was tested through
the use of paired Wilcoxon tests with a two-sided
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echocardiographic variability, we calculated an adjusted
coefficient of variation (CV), defined as the ratio of the
SD and the mean of absolute readings for each echocar-
diographic parameter. Agreements between results
obtained by the 2D and 3D approaches were tested
using Cohen’s coefficient of variation, Kappa statistics,
and with segment-to-segment comparison. A kappa sta-
tistic less than 0.40 was considered to represent poor
agreement, between 0.40 and 0.75 fair to good agree-
ment, and greater than 0.75 excellent agreement. The
95% CIs were calculated for each technique, and the
individual intervals were compared. Differences between
techniques were considered significant at the 0.05 level
when 95% CI did not overlap. All calculations were
made using SPSS software (SPSS version 13.0 for Win-
dows, 2004).
Results
Feasibility of imaging and population characteristics
One hundred eleven consecutive patients underwent 2D
and RT3D stress echocardiography (51 exercise echo, 31
dipyridamole echo, and 29 dobutamine echo) for known
or suspected coronary artery disease and or viability
identification. Ten patients (10%) were excluded for sub-
optimal acquisition of 3D images for translational arti-
fact or for atrial or ventricular arrhythmia precluding
analysis of left ventricular volume. RT3D images were
sub-optimal at rest in 17 patients (15%) (additional file
1 ,2a n d3 )a n da tp e a ks t r e s si n1 0p a t i e n t s( 9 % )f o r
other reasons such as patient decubitus during acquisi-
tion and/or artifacts at peak stress, high heart rate to
preclude endocardial border delineation for accurate
assessment of left ventricular volume and WMSI (addi-
tional file 4). These 37 patients were excluded from the
analysis. Therefore, the overall feasibility of RT3D stress
echo was 67%, higher for pharmacological stress echo
(12 excluded subjects/60 subjects) than for exercise (25
excluded subjects/51 subjects): 80% vs. 51% p < .0001
(figure 1). Clinical and echocardiographic characteristics
of the 74 patients with interpretable 2D and RT3D
images constituting the study population are shown in
Table 1.
RT3D stress test echo
No complications occurred during stress echocardiogra-
phy. Out of 74 patients, 28 subjects (38%) underwent
semi-supine exercise, 23 subjects (31%) dipyridamole
test, and 23 subjects (31%) dobutamine test. The mean
frame rate of RT3D echo during acquisition was 19 ±
3.8 Hz at rest and 18 ± 2.7 Hz at peak stress (p = n.s.).
The increase in heart rate during the three different
stressors is reported in Table 2. The mean WMSI at
rest was 1.31 ± 0.4 by 2D echo and 1.33 ± 0.43 by
RT3D echo (mean difference 0.01, 95% CI: -0.41 to 0.38,
p = 0.2). At peak stress the mean WMSI was 1.26 ± 0.4
by 2D echo and 1.25 ± 0.4 by RT3D echo (mean differ-
ence 0.01, 95% CI: -0.39 to 0.41, p = 0.6). The two
methods showed an excellent agreement in WMSI at
rest (Pearson’s correlation index 0.957, CI 95%: 0.85 to
0.98; p < .0001) and at peak stress (Pearson’s correlation
index 0.942, CI 95%: 0.85 to 1; p < .0001). The RT3D
image quality was deemed to be good/fair in 44 patients,
and only poor but adequate in 30 patients, and it was
better in patients submitted to exercise echo in compar-
ison to pharmacological stress (figure 2). This difference
is due to the fact that in our clinical practice, patients
with sub-optimal acoustic window are shifted to phar-
macological stress echocardiography.
2D and RT3D analysis and reproducibility of wall motion
of left ventricle
With 2D echocardiography, of all the potential 1241
segments, 1214 (97.8%) were visualized at rest and 1146
(92.3%) at peak stress. The inter-observer agreement for
2D echo was good at rest (kappa value = 0.75) and at
peak stress (kappa value = 0.70).
For 3D echo 1206 (97%) segments were visualized at
rest and 1108 (89%) at peak stress and the agreement
between the two different observers for 3D echo was
excellent at rest (kappa value 0.78) and at peak stress
(kappa value = 0.75).
We evaluated the agreement between the two obser-
vers by separating the total population according to
image quality at peak stress and patient decubitus dur-
ing the stress (semi-supine decubitus for exercise and
left lateral decubitus for pharmacological stressors). In
the presence of a bad quality image the agreement
between the two observers decreases significantly in the
case of semi-supine decubitus (k value = 0.88 with good
quality images and 0.69 with bad quality images). More-
over, when patients reached high heart rates, agreement
between the two observers significantly decreased both
in left lateral and semi-supine decubitus (k value: phar-
macological stress HR < 100 bpm = 0.83; HR ≥ 100
bpm = 0.49; Exercise stress HR < 100 bpm = 0.88; HR ≥
100 bpm = 0.78) (figure 3).
LVEDV, LVES by RT3D echo
RT3D measurements of LV volumes were feasible in all
patients (Table 1). In the population study there was an
excellent inter-observer agreement with the Bland Alt-
m a nm e t h o dw i t hm e a n±S Df o rL V E D Va tr e s t( 2 . 3±
18 ml; CI 95%: -38 ml to 34 ml; p = n.s.) and at peak
stress (5.8 ± 16 ml; CI 95%: -38 ml to 26 ml, p = 0.002),
LVESV at rest (3.6 ± 23 ml; CI 95%: -48 to 41 ml; p =
0.03) and at peak stress (0.3 ± 14 ml; CI 95%: -27 to 27
ml; p = n.s.). Moreover, we evaluated the inter-observer
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submitted to stress echo in left lateral decubitus (phar-
macological stress) and group B: semi-supine decubitus
(exercise stress); these two groups were further sepa-
rated on the basis of heart rate at peak stress. Variability
analyses of RT3D echocardiographic parameters are
shown in Table 3 and figure 4. The variability was high
for the LVEDV during exercise echo at high heart rates
(CV: 20%) and for LVESV, in both pharmacological and
exercise echo, especially with high heart rate (CV: 15.9%
for pharmacological echo and 26.5% for exercise echo).
The variability was low for LVED and LVES volumes
both for pharmacological and exercise echo at low heart
rates at peak stress.
In a subset of study patients (n = 17) the intra-obser-
ver variability was calculated. The 3D analyses of obser-
ver 1 were compared with those previously calculated in
a time-lag ranging from 12 to 18 months by the same
observer. In this subgroup the agreement was excellent
with the Bland Altman method with a mean ± SD for
LVEDV at rest (4.7 ± 11 ml; CI 95%: -27 ml to 17 ml)
and at peak stress (5 ± 15 ml; CI 95%: -34 ml to 24 ml),
LVESV at rest (3.4 ± 7 ml; CI 95%: -17 to 10 ml) and at
peak stress (1.17 ± 7.69 ml; CI 95%: -16.2 to 13.9 ml).
Figure 1 RT3D feasibility at rest: 27 patients were excluded from analysis because of translational artefact or for un-interpretable
images. Ten patients were excluded for un-interpretable images at peak stress. Of 37 RT3D echo tests excluded from analysis, 25 were exercise
and 12 pharmacological tests.
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RT3D SE is a feasible technique when applied to conse-
cutive patients evaluated for known or suspected coron-
ary artery disease, but some limitations of its
performance have to be acknowledged. The resolution
of the images was not as high as that obtained with con-
ventional scanners, due to the lower frame rates. The
American Society of Echocardiography recommends
that 20 frames/s are needed in the majority of examina-
tions, for digital capture and playback at normal heart
r a t e ,a n dt h a tf r a m er a t es h o u l db ei n c r e a s e dt o3 0
frames/s when heart rate is > 140 bpm, [14]. Real Time
3D scans are at a speed of 18 to 40 frames/s as deter-
mined by depth settings. The frame rate at 15 cm depth
setting is 20 frames/s. Thus the low frame rate may
limit the feasibility of RT3D SE. In our study the mean
frame rate was low at rest and at peak stress and this
may account for the low feasibility of the RT3D SE,
which is only 67%. The position of the patient (semi-
supine worse than lateral decubitus) during acquisition
could also contribute to the low feasibility; as a matter
of fact all the patients excluded from analysis underwent
exercise stress echo which is performed in semi-supine
decubitus. An other important limitation for feasibility
and reproducibility in RT3D SE was the high heart rates
reached at peak stress. As demonstrated in the present
study, the agreement of WMSI assessment between two
independent observers decreased significantly when
heart rate was independent of patient decubitus during
stress test. In this study we also evaluated the feasibility
and reproducibility of LVED and ES volumes at rest and
at peak stress when different stressors are used. The LV
volume measurements by 3D have a low or moderate
inter-observer and intra-observer variability at low heart
rates at peak stress. In conclusion during RT3D SE, wall
motion analysis is blunted by unacceptably low reprodu-
cibility when exercise is the stressor of choice, with rest-
ing images of only adequate quality and _ even for
resting images of good quality _ when heart rate exceeds
100 b/m. In this study the quantification of left ventricu-
lar volumes were reproducible during stress also when
heart rate was high or resting images of sub-optimal
quality. However, when applied on a consecutive
patients population, the overall diagnostic accuracy of
RT3D stress echocardiography is significantly lower
than 2D.
Comparison with preview studies
Zwas et al [12] had demonstrated that with an earlier
generation of 3D scanners, treadmill stress testing is fea-
sible in healthy volunteers. With the first-generation 3D
echocardiography two studies showed that RT3D dobu-
tamine SE showed similar sensitivity as 2D dobutamine
echo for the detection of myocardial ischemia [7,11].
Matsumura et al. [8] using a second-generation RT3D
echo system showed a trend toward a better sensitivity
f o rR T 3 De c h ot h a n2 De c h oi nt h el e f ta n t e r i o rd e s -
cending artery territory, using single-photon emission
computed tomography as the reference standard. Also
in the study published by Aggeli C et al [15], RT3D
echo identified wall motion abnormalities more readily
in the apical region than 2D echo and in this study the
results were validated with coronary angiography. Only
one study has shown that RT3D dipyridamole stress
Table 1 Clinical and RT3D echocardiographic patient
characteristics
Variables n = 74 pts
















ACE inhibitors 46 (62%)
Beta-blockers 41 (55%)
Nitrates 18 (24%)




Rest LVED volume (ml) 119 ± 59
Rest LVES volume (ml) 64 ± 48
Peak LVED volume (ml) 111 ± 54
Peak LVES volume (ml) 58 ± 42
MI: myocardial infarction, PCI; Percutaneous coronary interventions;
CABG; Coronary artery bypass graft; LVED: Left ventricular end-diastolic;
LVES: Left ventricular end-systolic.
Table 2 Heart rate at rest and peak of stress
Test Heart rate: Rest (bpm) Heart rate: Peak (bpm)
Exercise 73 ± 15 127 ± 23
Dipyridamole 67 ± 9 80 ± 10
Dobutamine 68 ± 13 104 ± 20
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dance rate with 2D standard stress echo [16]. Consis-
tently with previous studies, in this paper [16] it was
shown that 2D images need a longer time of acquisition
but that RT-3D is more time-consuming for analysis.
Clinical implications RT3D has entered the clinical
arena but no additional advantage over conventional 2D
echocardiography during SE can be demonstrated. The
recent EAE [13] consensus statement on SE did not
Figure 2 Distribution of patients according to RT3D image quality separating the study group into pharmacological and exercise
stress echo.
Figure 3 Agreement between two different observers for the evaluation of RT3D WMSI considering two different groups: exercise
and pharmacological stress echo. In the graph the K value according to image quality and heart rate at peak stress is reported.
Table 3 Inter-observer variability summary
Inter-observer CV%
RT3D echo measure Pharmacological echo Exercise echo
Rest LVED volume (ml) 6.1 11.2
Peak LVED volume (ml) 0.1 12.5
Rest LVES volume (ml) 4.6 17.2
Peak LVES volume (ml) 0.2 3.9
LVED: Left ventricular end-diastolic; LVES: Left ventricular end-systolic.
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though it may significantly shorten time of acquisition
counterbalanced by a longer time of data-set analysis.
Clinically driven application of RT3D should be based
mainly _ if not only_ on robust indices incorporating
LV volumes (such as ventricular and vascular elastance
or mean diastolic filling rates). 2D echo outperforms
RT3D echo for regional wall motion assessment but the
latter is better for global indices of left ventricular func-
tion. Several conclusions can be drawn on the basis of
the present results: first, not all patients were created
equal: in case of sub-optimal image quality at rest, feasi-
bility is lower for exercise and patients should be
re-directed to pharmacological tests. Second, not all stres-
sors were created equal: at peak stress, exercise is less
feasible than pharmacological stressors, mostly due to
tachycardia image degradation. Lastly, during stress, not
all parameters were created equal: the worst reproducibil-
ity was obtained for wall motion analysis, the best for LV
ESV and EDV at low heart rate (HR < 100 bpm).
Additional file 1: example movies of good quality movie at rest
with RT3D echo. good quality image of a 4-chamber left ventricle.
Additional file 2: example movies of suboptimal quality movie at
rest with RT3D echo. sub-optimal image due of a 4-chamber left
ventricle to artefacts.
Additional file 3: example movies of uniterpretable movie at rest
with RT3D echo. uninterpretable image of a 4-chamber left ventricle for
bad acoustic window.
Additional file 4: example movies of good acoustic window at rest
both 2D and 3d acquisitions, and uninterpretable echo images at
peak stress. Patient with optimal acoustic window in rest condition (left
part of movie) but uninterpretable images at peak stress (right part of
movie). Upper part 2D acquisition, lower part 3D acquisition.
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